A Study on the Safety and Efficacy of TQB3473 Tablets in the Treatment of Persistent or Chronic Primary Immune Thrombocytopenia (ITP) in Adults
Clinical trial NCT07083739 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07083739
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2027-09-01
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.